A leaked draft from trade talks involving New Zealand shows pharmaceutical companies want patent rights strengthened, reducing peoples' access to cheaper substitutes.
A leaked draft from trade talks involving New Zealand shows pharmaceutical companies want patent rights strengthened, reducing peoples' access to cheaper substitutes.